Azioni Biotie Therapies Corp OTC Markets

Azioni

Prezzo di chiusura OTC Markets Altri mercati azionari			Variaz. 5gg	Var. 1 gen.
- ^USD	-.--%		-.--%	-.--%

Durata

Periodo

Stile

Biotie Therapies : ACORDA GAINS TITLE TO BIOTIE SHARES AND THE SHARES WILL DELIST	30/09/16
Biotie Therapies : ARBITRAL TRIBUNAL CONFIRMED ACORDA'S REDEMPTION RIGHT REGARDING BIOTIE SHARES AND BIOTIE SHARES TRADING HAS BEEN TERMINATED	26/09/16
Biotie: BTT1023 receives Orphan Drug Designation in the United States	26/08/16
Biotie Therapies : THE LISTING COMMITTEE OF NASDAQ HELSINKI HAS RESOLVED TO DELIST THE SHARES OF BIOTIE THERAPIES CORP.	25/08/16
Biotie Therapies : CORP. APPLIES FOR DELISTING OF ITS SHARES FROM NASDAQ HELSINKI	18/08/16

Dirigenti	Titolo	Età	Da
Antero Kallio CEO	Chief Executive Officer	64	01/06/05

Amministratori	Titolo	Età	Da
Ronald Cohen CHM	Chairman	68	01/05/16
Jane Wasman BRD	Director/Board Member	67	01/05/16
Andrew Hindman BRD	Director/Board Member	51	01/12/16

Settore

	Variaz. 1 gen.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+9,83%	118 Mrd
REGENERON PHARMACEUTICALS, INC.	+10,80%	106 Mrd
BIONTECH SE	-10,84%	23,4 Mrd
ARGENX SE	-1,69%	22,1 Mrd
GENMAB A/S	-10,23%	18,34 Mrd
WUXI APPTEC CO., LTD.	-41,92%	16,59 Mrd
BEIGENE, LTD.	-15,11%	15,97 Mrd
NEUROCRINE BIOSCIENCES, INC.	+6,62%	14,03 Mrd
SAREPTA THERAPEUTICS, INC.	+17,53%	11,67 Mrd